Micro Labs Company Profile
✉ Email this page to a colleague
What is the competitive landscape for MICRO LABS
MICRO LABS has one hundred and nine approved drugs.
There are ten tentative approvals on MICRO LABS drugs.
Summary for Micro Labs
| US Patents: | 0 |
| Tradenames: | 99 |
| Ingredients: | 99 |
| NDAs: | 109 |
| Patent Litigation for Micro Labs: | See patent lawsuits for Micro Labs |
| PTAB Cases with Micro Labs as petitioner: | See PTAB cases with Micro Labs as petitioner |
Drugs and US Patents for Micro Labs
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Micro Labs | ROFLUMILAST | roflumilast | TABLET;ORAL | 208180-002 | Apr 18, 2023 | AB | RX | No | No | ⤷ Start Trial | ⤷ Start Trial | ||||
| Micro Labs Ltd India | AMOXICILLIN AND CLAVULANATE POTASSIUM | amoxicillin; clavulanate potassium | FOR SUSPENSION;ORAL | 205187-001 | May 21, 2021 | AB | RX | No | No | ⤷ Start Trial | ⤷ Start Trial | ||||
| Micro Labs | DAPAGLIFLOZIN AND METFORMIN HYDROCHLORIDE | dapagliflozin; metformin hydrochloride | TABLET, EXTENDED RELEASE;ORAL | 211466-003 | Apr 6, 2026 | AB | RX | No | No | ⤷ Start Trial | ⤷ Start Trial | ||||
| Micro Labs | METOLAZONE | metolazone | TABLET;ORAL | 217563-002 | Nov 6, 2024 | AB | RX | No | No | ⤷ Start Trial | ⤷ Start Trial | ||||
| Micro Labs | DOXEPIN HYDROCHLORIDE | doxepin hydrochloride | CAPSULE;ORAL | 217688-005 | Jun 27, 2023 | AB | RX | No | No | ⤷ Start Trial | ⤷ Start Trial | ||||
| Micro Labs | GLIMEPIRIDE | glimepiride | TABLET;ORAL | 091220-003 | Jun 29, 2012 | RX | No | No | ⤷ Start Trial | ⤷ Start Trial | |||||
| Micro Labs | PIROXICAM | piroxicam | CAPSULE;ORAL | 206152-001 | Dec 29, 2017 | AB | RX | No | No | ⤷ Start Trial | ⤷ Start Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.
Here is a list of applicants with similar names.
